
New antihypertensive targets difficult-to-treat patients
Drug is the first new IV antihypertensive treatment approved in 10 years.
Patients who are not managed properly on oral blood pressure medications have a new option available to them. It's Medicines Co.'s
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































